首页> 外文期刊>癌と化学療法 >A case of advanced gastric cancer with malignant ascites responding to weekly paclitaxel therapy
【24h】

A case of advanced gastric cancer with malignant ascites responding to weekly paclitaxel therapy

机译:具有恶性腹水晚期胃癌的病例,对每周紫杉醇治疗进行响应

获取原文
获取原文并翻译 | 示例
           

摘要

A 54-year-old woman with scirrhous gastric cancer in the upper third area was admitted to our hospital. She was diagnosed with advanced gastric cancer that was inoperable due to peritoneal metastasis, so weekly paclitaxel (PTX) therapy was carried out. After 2 courses, malignant ascites completely disappeared and bilateral hydronephrosis improved. After 4 courses, no ascites or hydronephrosis were seen. Only neutropenia (grade 2) and alopecia (grade 1) were observed as adverse events during the therapy, but no major adverse events were noted. We also investigated the concentration of paclitaxel in ascites. Two hours after intravenous injection of PTX, the concentration of PTX in ascites rose over the reported cytotoxic dose of PTX, and this available concentration was maintained after 48 hours. Weekly paclitaxel therapy is suggested to be one of the safe and useful treatments for advanced gastric cancer with malignant ascites.
机译:在第三个地区的一个54岁的女性中,患有乳糜胃癌的胃癌被录取到我们的医院。 她被诊断出患有晚期胃癌,由于腹膜转移而无法操作,因此进行每周紫杉醇(PTX)治疗。 经过2个课程,恶性腹水完全消失,双侧肾内肾小粒改善。 在4个课程之后,没有看到腹水或肾内肾复子。 在治疗期间只观察到中性粒细胞减少症(2级)和脱发(1级)作为不良事件,但没有注意到主要不良事件。 我们还在腹水中调查了紫杉醇的浓度。 静脉注射PTX后两小时,腹水中PTX的浓度在报道的PTX中升高,并在48小时后保持该可用浓度。 每周紫杉醇治疗被认为是具有恶性腹水的晚期胃癌的安全和有益的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号